Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1886 1
1901 1
1975 1
1979 1
1984 2
1985 1
1995 1
1997 1
1999 2
2000 1
2006 3
2007 1
2008 2
2009 3
2010 3
2011 5
2012 3
2013 10
2014 7
2015 6
2016 5
2017 7
2018 11
2019 10
2020 11
2021 20
2022 18
2023 22
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial.
Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C, Greco SC, Wang H, Denmeade SR, Paller CJ, Dipasquale S, DeWeese TL, Song DY, Wang H, Carducci MA, Pienta KJ, Pomper MG, Dicker AP, Eisenberger MA, Alizadeh AA, Diehn M, Tran PT. Phillips R, et al. JAMA Oncol. 2020 May 1;6(5):650-659. doi: 10.1001/jamaoncol.2020.0147. JAMA Oncol. 2020. PMID: 32215577 Free PMC article. Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: The Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (ORIOLE) phase 2 randomized study accrued participants from 3 US radiation treatment facilities affiliated with a university hospital from May 2016 to …
DESIGN, SETTING, AND PARTICIPANTS: The Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (ORIOLE) ph …
Long-Term Outcomes and Genetic Predictors of Response to Metastasis-Directed Therapy Versus Observation in Oligometastatic Prostate Cancer: Analysis of STOMP and ORIOLE Trials.
Deek MP, Van der Eecken K, Sutera P, Deek RA, Fonteyne V, Mendes AA, Decaestecker K, Kiess AP, Lumen N, Phillips R, De Bruycker A, Mishra M, Rana Z, Molitoris J, Lambert B, Delrue L, Wang H, Lowe K, Verbeke S, Van Dorpe J, Bultijnck R, Villeirs G, De Man K, Ameye F, Song DY, DeWeese T, Paller CJ, Feng FY, Wyatt A, Pienta KJ, Diehn M, Bentzen SM, Joniau S, Vanhaverbeke F, De Meerleer G, Antonarakis ES, Lotan TL, Berlin A, Siva S, Ost P, Tran PT. Deek MP, et al. J Clin Oncol. 2022 Oct 10;40(29):3377-3382. doi: 10.1200/JCO.22.00644. Epub 2022 Aug 24. J Clin Oncol. 2022. PMID: 36001857 Free PMC article.
Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported.The initial STOMP and ORIOLE trial reports suggested that metastasis-directed therapy (MDT …
Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the p …
Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study.
Weiss SL, Fitzgerald JC, Pappachan J, Wheeler D, Jaramillo-Bustamante JC, Salloo A, Singhi SC, Erickson S, Roy JA, Bush JL, Nadkarni VM, Thomas NJ; Sepsis Prevalence, Outcomes, and Therapies (SPROUT) Study Investigators and Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Weiss SL, et al. Am J Respir Crit Care Med. 2015 May 15;191(10):1147-57. doi: 10.1164/rccm.201412-2323OC. Am J Respir Crit Care Med. 2015. PMID: 25734408 Free PMC article.
Prostate cancer-what about oligometastatic disease and stereotactic ablative radiotherapy?-a narrative review.
Mikropoulos C, Saxby H, Boussios S. Mikropoulos C, et al. Ann Palliat Med. 2023 May;12(3):646-652. doi: 10.21037/apm-22-828. Epub 2023 Mar 2. Ann Palliat Med. 2023. PMID: 37038063 Free article. Review.
We now have evidence to support that disease control can be optimised with SABR as shown in several practice changing trials including 'ORIOLE', 'STOMP' for PrCa and 'SABR-COMET' showing a survival advantage with a tumour agnostic salvage approach. ...
We now have evidence to support that disease control can be optimised with SABR as shown in several practice changing trials including 'O …
The role of radiotherapy in oligometastatic hormone-sensitive prostate cancer.
Abdel-Aty H, James ND. Abdel-Aty H, et al. Curr Opin Urol. 2022 May 1;32(3):277-282. doi: 10.1097/MOU.0000000000000980. Epub 2022 Mar 4. Curr Opin Urol. 2022. PMID: 35249966 Review.
Metastases-directed therapy (MDT) with stereotactic ablative radiotherapy (SABR) in the STOMP and ORIOLE trial reported excellent local control and a survival advantage in metachronous oligometastatic HSPC. ...
Metastases-directed therapy (MDT) with stereotactic ablative radiotherapy (SABR) in the STOMP and ORIOLE trial reported excellent loc …
[Stereotactic body radiation therapy for oligometastatic prostate cancer].
Bibault JE. Bibault JE. Bull Cancer. 2018 Jan;105(1):120-125. doi: 10.1016/j.bulcan.2017.09.017. Epub 2017 Nov 27. Bull Cancer. 2018. PMID: 29191358 Review. French.
The effect of SBRT on disease-free or global survival and quality of life has not been assessed. Several prospective trials (STOMP & ORIOLE) are underway. CONCLUSION: Treating patients with up to five prostate cancer metastases is efficient and has a low toxicity. ...
The effect of SBRT on disease-free or global survival and quality of life has not been assessed. Several prospective trials (STOMP & …
Medical ethics in pediatric critical care.
Orioles A, Morrison WE. Orioles A, et al. Crit Care Clin. 2013 Apr;29(2):359-75. doi: 10.1016/j.ccc.2012.12.002. Epub 2013 Feb 8. Crit Care Clin. 2013. PMID: 23537680 Review.
149 results